It is known that ox-LDL, TNF-α, IL-6, and other atherosclerosis stimuli remain at a high level in ACS patients for a long time, which may lead to the adaptive upregulation of the expression and activity of antioxidant enzymes in the affected cells. This evidence concerns the gene IL6 and atherosclerosis.